13F

Stock

Cellectar Biosciences, Inc.

CLRB · held by 19 managers

Reported value

$812.9K

Holders

19

+1 new · −4 exited

Holders’ est. mark

−$69.8K

Price effect on 15 books still in the name

Largest holder

$254K

Bleichroeder LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Bleichroeder LP100K$254K−$41KCut−$41K
VANGUARD CAPITAL MANAGEMENT LLC81.9K$208KHeld
GEODE CAPITAL MANAGEMENT, LLC52.8K$134.1K−$11.7KAdded$49.6K
Riverview Capital Advisers, LLC10.4K$50.1K$0Held
Sequoia Financial Advisors, LLC18.9K$47.9K−$7.73KCut−$26.9K
VANGUARD FIDUCIARY TRUST CO16.6K$42.1KHeld
Warberg Asset Management LLC13.9K$35.3K−$5.7KCut−$5.7K
UBS Group AG9.65K$24.5K−$1.06KAdded$16.8K
BlackRock, Inc.4.75K$12.1K−$1.95KCut−$1.95K
Tower Research Capital LLC (TRC)793$2.01K−$325Cut−$3.39K
Vanguard Global Advisers, LLC563$1.43KHeld
MORGAN STANLEY510$1.29K−$210Cut−$210
TD Waterhouse Canada Inc.63$154−$27Cut−$27
SBI Securities Co., Ltd.11$28−$4Cut−$4
Fidelity10$25New
JONES FINANCIAL COMPANIES LLLP3$8−$1Cut−$1
US BANCORP \DE\3$8−$1Cut−$1
DANSKE BANK A/S2$5−$1Cut−$1
OSAIC HOLDINGS, INC.1$2−$1Cut−$17

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.